ZD 1839 in patients with brain metastases from non-small-cell lung cancer (NSCLC): report of four casesCAPPUZZO, F; CALANDRI, C; BARTOLINI, S et al.British journal of cancer. 2003, Vol 89, Num 2, pp 246-247, issn 0007-0920, 2 p.Article

Gefitinib as first-line treatment for patients with advanced non-small-cell lung cancer with activating Epidermal Growth Factor Receptor mutation: Implications for clinical practice and open issuesGRIDELLI, C; DE MARINIS, F; DI MAIO, M et al.Lung cancer. 2011, Vol 72, Num 1, pp 3-8, issn 0169-5002, 6 p.Article

EGFR fluorescence in situ hybridisation assay: guidelines for application to non-small-cell lung cancerVARELLA-GARCIA, M; DIEBOLD, J; CAPPUZZO, F et al.Journal of clinical pathology. 2009, Vol 62, Num 11, pp 970-977, issn 0021-9746, 8 p.Article

Phase II study of gemcitabine plus oxaliplatin as first-line chemotherapy for advanced non-small-cell lung cancerCAPPUZZO, F; NOVELLO, S; MARINI, L et al.British journal of cancer. 2005, Vol 93, Num 1, pp 29-34, issn 0007-0920, 6 p.Article

HER2 gene copy number status may influence clinical efficacy to anti-EGFR monoclonal antibodies in metastatic colorectal cancer patientsMARTIN, V; LANDI, L; KALOGERAS, K. T et al.British journal of cancer. 2013, Vol 108, Num 3, pp 668-675, issn 0007-0920, 8 p.Article

Gefitinib as first-line treatment for patients with advanced non-small-cell lung cancer with activating epidermal growth factor receptor mutation: Review of the evidenceGRIDELLI, C; DE MARINIS, F; DI MAIO, M et al.Lung cancer. 2011, Vol 71, Num 3, pp 249-257, issn 0169-5002, 9 p.Article

Insulin-like growth factor receptor 1 (IGFR-1) is significantly associated with longer survival in non-small-cell lung cancer patients treated with gefitinibCAPPUZZO, F; TOSCHI, L; TRISOLINI, R et al.Annals of oncology. 2006, Vol 17, Num 7, pp 1120-1127, issn 0923-7534, 8 p.Article

Survival benefit with erlotinib maintenance therapy in patients with advanced non-small-cell lung cancer (NSCLC) according to response to first-line chemotherapyCOUDERT, B; CIULEANU, T; PARK, K et al.Annals of oncology. 2012, Vol 23, Num 2, pp 388-394, issn 0923-7534, 7 p.Article

EGFR FISH assay predicts for response to cetuximab in chemotherapy refractory colorectal cancer patientsCAPPUZZO, F; FINOCCHIARO, G; DESTRO, A et al.Annals of oncology. 2008, Vol 19, Num 4, pp 717-723, issn 0923-7534, 7 p.Article

Primary resistance to cetuximab therapy in EGFR FISH-positive colorectal cancer patientsCAPPUZZO, F; VARELLA-GARCIA, M; HOLMES, A. J et al.British journal of cancer. 2008, Vol 99, Num 1, pp 83-89, issn 0007-0920, 7 p.Article

Efficacy and tolerability of gefitinib in pretreated elderly patients with advanced non-small-cell lung cancer (NSCLC)CAPPUZZO, F; BARTOLINI, S; CRINO, L et al.British journal of cancer. 2004, Vol 90, Num 1, pp 82-86, issn 0007-0920, 5 p.Article

Gefitinib in patients with brain metastases from non-small-cell lung cancer: a prospective trialCERESOLI, G. L; CAPPUZZO, F; GREGORC, V et al.Annals of oncology. 2004, Vol 15, Num 7, pp 1042-1047, issn 0923-7534, 6 p.Article

A phase II randomized study evaluating the addition of iniparib to gemcitabine plus cisplatin as first-line therapy for metastatic non-small-cell lung cancerNOVELLO, S; BESSE, B; CARCERENY, E et al.Annals of oncology. 2014, Vol 25, Num 11, pp 2156-2162, issn 0923-7534, 7 p.Article

Correlation of cytidine deaminase polymorphisms and activity with clinical outcome in gemcitabine-/platinum- treated advanced non-small-cell lung cancer patientsTIBALDI, C; GIOVANNETTI, E; PETERS, G. J et al.Annals of oncology. 2012, Vol 23, Num 3, pp 670-677, issn 0923-7534, 8 p.Article

Increased MET and HGF gene copy numbers are associated with trastuzumab failure in HER2-positive metastatic breast cancerMINUTI, G; CAPPUZZO, F; JANKOWSKI, T et al.British journal of cancer. 2012, Vol 107, Num 5, pp 793-799, issn 0007-0920, 7 p.Article

Insulin-like growth factor receptor 1 (IGF1R) expression and survival in surgically resected non-small-cell lung cancer (NSCLC) patientsCAPPUZZO, F; TALLINI, G; RONCALLI, M et al.Annals of oncology. 2010, Vol 21, Num 3, pp 562-567, issn 0923-7534, 6 p.Article

Surrogate predictive biomarkers for response to anti-EGFR agents : state of the art and challengesCAPPUZZO, F; TOSCHI, L; FINOCCHIARO, G et al.The International journal of biological markers. 2007, Vol 22, Num 1, issn 0393-6155, S10-S23, SUP4Article

Glutamine supplementation in cancer patients receiving chemotherapy : A double-blind randomized studyBOZZETTI, F; BIGANZOLI, L; GAVAZZI, C et al.Nutrition (Burbank, Los Angeles County, Calif.). 1997, Vol 13, Num 7-8, pp 748-751, issn 0899-9007Conference Paper

Efficacy of everolimus (RAD001) in patients with advanced NSCLC previously treated with chemotherapy alone or with chemotherapy and EGFR inhibitorsSORIA, J.-C; SHEPHERD, F. A; DI SCALA, L et al.Annals of oncology. 2009, Vol 20, Num 10, pp 1674-1681, issn 0923-7534, 8 p.Article

MET increased gene copy number and primary resistance to gefitinib therapy in non-small-cell lung cancer patientsCAPPUZZO, F; JÄNNE, P. A; DESTRO, A et al.Annals of oncology. 2009, Vol 20, Num 2, pp 298-304, issn 0923-7534, 7 p.Article

Predictive value of EGFR and HER2 overexpression in advanced non-small-cell lung cancerHIRSCH, F. R; VARELLA-GARCIA, M; CAPPUZZO, F et al.Oncogene (Basingstoke). 2009, Vol 28, issn 0950-9232, S32-S37, SUP1Article

Combination of EGFR gene copy number and protein expression predicts outcome for advanced non-small-cell lung cancer patients treated with gefitinibHIRSCH, F. R; VARELLA-GARCIA, M; GAZDAR, A. F et al.Annals of oncology. 2007, Vol 18, Num 4, pp 752-760, issn 0923-7534, 9 p.Article

Evolution and future perspectives in the treatment of locally advanced non-small cell lung cancerTOSCHI, L; CAPPUZZO, F; JÄNNE, P. A et al.Annals of oncology. 2007, Vol 18, issn 0923-7534, ix150-ix155, SUP9Conference Paper

Multicenter phase II study of trastuzumab in combination with epirubicin and docetaxel as first-line treatment for HER2-overexpressing metastatic breast cancerVENTURINI, M; BIGHIN, C; MONFARDINI, S et al.Breast cancer research and treatment. 2006, Vol 95, Num 1, pp 45-53, issn 0167-6806, 9 p.Article

First-line chemotherapy with planned sequential administration of cisplatin/gemcitabine followed by docetaxel in elderly 'unfrail' patients with advanced non-small-cell lung cancer: a multicenter phase II studyTIBALDI, C; CAMERINI, A; D'INCECCO, A et al.Journal of cancer research and clinical oncology. 2012, Vol 138, Num 12, pp 2003-2008, issn 0171-5216, 6 p.Article